5 Followers on Owler
Actuate is a Texas-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer... Read more
OverviewCompetitorsFundingNews & Insights
Actuate is a Texas-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer... Read more
Actuate Therapeutics President & CEO: Daniel M. Schmitt

President & CEO

Daniel M. Schmitt

CEO Approval Rating

90/100

2015

PublicNASDAQACTU

Pharmaceuticals & Biotechnology
BiotechnologyPharmaceuticals
28342836 NAICS listing

Annual Revenue
<$1M
Employees
10
Funding
$117.9M

News

Funding
Sep 12, 2025
GlobalNewswire
Actuate Therapeutics received $17.3M in Post-IPO Equity Funding

Actuate Therapeutics Competitors

1NexImmune
2TScan
3Kite Pharma
4RayzeBio
5Jounce
6Apexigen
7Merrimack
8Juno Therapeutics
9Inovio
10bluebird bio
Unlock 25 + competitors

Trending Companies